Company: FLDDW
Filing Date: 2025-01-24
Form Type: 424B3
Source: 0001213900-25-006075
Chunk: 77

Company: Fold Holdings, Inc.
Filing Date: 2025-01-24
Form: 424B3
Chunk 77
---
 “would” and similar expressions may identify forward -lookingstatements, but the absence of these words does not mean that a statement is not forward -looking. Forward -lookingstatements in this proxy statement/prospectus may include, for example, statements about: •the ability to complete the Business Combination with Fold or, if Emerald does not consummate such Business Combination, any other initial business combination; •the anticipated timing of the Business Combination; •New Fold’s capitalization after giving effect to the Business Combination; •the ability to recognize the anticipated benefits of the proposed Business Combination; •satisfaction or waiver of the conditions to the Business Combination including, among others: (i) the approval of the holders of the requisite number of outstanding shares of Emerald Common Stock entitled to vote, who attend and vote thereupon at the special meeting, (ii) the Requisite Approval, (iii) the Registration Statement (of which this proxy statement/prospectus is a part) will have been declared effective under the Securities Act and remains effective as of such date, (iv) all waiting periods (and any extensions thereof) under the HSR Act shall have expired or been terminated, (v) no governmental authority with jurisdiction over the parties with respect to the Business Combination will have issued any order or law enjoining, prohibiting or making illegal the consummation of the Business Combination, and (vi) New Fold Common Stock to be issued in connection with the Business Combination shall have been approved for listing on Nasdaq; •the financial and business performance of New Fold, including financial projections and business metrics and any underlying assumptions thereunder; •the ability to obtain and/or maintain the listing of New Fold’s Common Stock and the Public Warrants on Nasdaq following the Business Combination; •the potential liquidity and trading of our public securities; •changes in Fold’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; •the implementation, market acceptance and success of Fold’s business model; •Fold’s ability to scale in a cost -effectivemanner; •developments and projections relating to Fold’s competitors and industry; •the impact of health epidemics on Fold’s business and the actions Fold may take in response thereto; •expectations regarding the time during which we will be an emerging growth company under the JOBS Act; •Fold’s future capital requirements and sources and uses of cash; •Fold’s ability to obtain funding for its operations; •Fold’s business, expansion plans and opportunities; 41 •